Bevacizumab in recurrent high-grade glioma: a single institution retrospective analysis on 92 patients
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1826-6983
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Bevacizumab in recurrent high-grade glioma: a single institution retrospective analysis on 92 patients ; volume:126 ; number:9 ; day:3 ; month:6 ; year:2021 ; pages:1249-1254 ; date:9.2021
La Radiologia medica ; 126, Heft 9 (3.6.2021), 1249-1254, 9.2021
- Urheber
-
Detti, Beatrice
Scoccianti, Silvia
Teriaca, Maria Ausilia
Maragna, Virginia
Lorenzetti, Victoria
Lucidi, Sara
Bellini, Chiara
Greto, Daniela
Desideri, Isacco
Livi, Lorenzo
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11547-021-01381-5
- URN
-
urn:nbn:de:101:1-2021110521415228460072
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:31 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Detti, Beatrice
- Scoccianti, Silvia
- Teriaca, Maria Ausilia
- Maragna, Virginia
- Lorenzetti, Victoria
- Lucidi, Sara
- Bellini, Chiara
- Greto, Daniela
- Desideri, Isacco
- Livi, Lorenzo
- SpringerLink (Online service)
Ähnliche Objekte (12)
Radiotherapy versus combination radiotherapy-bevacizumab for the treatment of recurrent high-grade glioma: a systematic review
Mechanism and significance of diffusion restriction followed by calcification in high-grade glioma treated with bevacizumab
Efficacy and indications of gamma knife radiosurgery for recurrent low-and high-grade glioma
Multifocal high-grade glioma radiotherapy safety and efficacy
Anlotinib alone or in combination with bevacizumab in the treatment of recurrent high-grade glioma: a prospective single-arm, open-label phase II trial
How I treat recurrent pediatric high-grade glioma (pHGG): a Europe-wide survey study
Regorafenib for recurrent high-grade glioma: a unicentric retrospective analysis of feasibility, efficacy, and toxicity
How I treat recurrent pediatric high-grade glioma (pHGG): a Europe-wide survey study
Regorafenib for recurrent high-grade glioma: a unicentric retrospective analysis of feasibility, efficacy, and toxicity
A prognostic neural epigenetic signature in high-grade glioma
A prognostic neural epigenetic signature in high-grade glioma
Signaling pathways and mesenchymal transition in pediatric high-grade glioma
Radiotherapy versus combination radiotherapy-bevacizumab for the treatment of recurrent high-grade glioma: a systematic review
Mechanism and significance of diffusion restriction followed by calcification in high-grade glioma treated with bevacizumab
Efficacy and indications of gamma knife radiosurgery for recurrent low-and high-grade glioma
Multifocal high-grade glioma radiotherapy safety and efficacy
Anlotinib alone or in combination with bevacizumab in the treatment of recurrent high-grade glioma: a prospective single-arm, open-label phase II trial
How I treat recurrent pediatric high-grade glioma (pHGG): a Europe-wide survey study
Regorafenib for recurrent high-grade glioma: a unicentric retrospective analysis of feasibility, efficacy, and toxicity
How I treat recurrent pediatric high-grade glioma (pHGG): a Europe-wide survey study
Regorafenib for recurrent high-grade glioma: a unicentric retrospective analysis of feasibility, efficacy, and toxicity
A prognostic neural epigenetic signature in high-grade glioma
A prognostic neural epigenetic signature in high-grade glioma
Signaling pathways and mesenchymal transition in pediatric high-grade glioma
Radiotherapy versus combination radiotherapy-bevacizumab for the treatment of recurrent high-grade glioma: a systematic review
Mechanism and significance of diffusion restriction followed by calcification in high-grade glioma treated with bevacizumab
Efficacy and indications of gamma knife radiosurgery for recurrent low-and high-grade glioma
Multifocal high-grade glioma radiotherapy safety and efficacy
Anlotinib alone or in combination with bevacizumab in the treatment of recurrent high-grade glioma: a prospective single-arm, open-label phase II trial
How I treat recurrent pediatric high-grade glioma (pHGG): a Europe-wide survey study
Regorafenib for recurrent high-grade glioma: a unicentric retrospective analysis of feasibility, efficacy, and toxicity
How I treat recurrent pediatric high-grade glioma (pHGG): a Europe-wide survey study
Regorafenib for recurrent high-grade glioma: a unicentric retrospective analysis of feasibility, efficacy, and toxicity
A prognostic neural epigenetic signature in high-grade glioma
A prognostic neural epigenetic signature in high-grade glioma